For most of VeinTrain's history, scale meant more courses, more trainers, more dates in the diary, logisitcs. That changed when we created the VeinTrainer. A recent visit to the UK press that manufactures VeinTrain's vein simulation products, Midland Regional Printers (MRP) in Nottingham, marked something more significant than a single production run: proof that VeinTrain can now manufacture training products in the UK, at volume, to a consistent standard.

Sarah Phillips, Founder and CEO of VeinTrain, filmed the visit herself. The video is informal by design, a founder walking the production floor rather than a corporate reel, but it captures something a polished video cannot: what it actually looks like when a training company moves from delivering sessions to building infrastructure. A more considered, professionally produced version is in progress, but there was no reason to wait for it before sharing this milestone.

Video: the production run walkthrough, filmed by Sarah Phillips

 

Why UK manufacturing matters

Training organisations do not normally think about manufacturing. VeinTrain has had to, because the Structured Learning Programme which is packed into the newly developed Ai Vein depends on physical vein simulation products that are consistent, well made and available at the volumes that hospitals, regional networks and international partners now need.

Producing them in the UK gives VeinTrain direct oversight of quality (literally standing over the print press and adjusting the skin tone in real time) , shorter lead times, and the ability to adapt designs quickly as the Structured Learning Programme evolves. It also keeps the manufacturing story inside the same relationships and evidence base as the training itself, rather than outsourcing it to a supplier VeinTrain does not control.

This recent production run, developed and delivered alongside an international medical device manufacturing partner, is the clearest sign yet that this capability is real, not aspirational. Full detail on that partnership will follow once it can be confirmed for public release; the manufacturing capacity behind it is already proven.

 

Scaling is not just making more products

It would be easy to describe this as VeinTrain "making more simulators". That undersells what is actually happening.

Scaling training infrastructure means building the routes around the product, not just the product itself: a QR code on the packaging that takes a learner straight to the right point in their learning journey, trainer support that travels with the product wherever it lands, evidence that sits behind every claim VeinTrain makes about what the training achieves, and an implementation structure, through HALO, that helps an organisation embed the skill rather than simply issue a certificate.

That last point matters more than any production number. A VeinTrain certificate documents training and learning activity. It has never replaced local competency sign-off, supervision or an employer's own scope of practice, and scaling production does not change that. If anything, scaling makes the distinction more important: the more organisations VeinTrain supports, the more consistently that boundary has to be held.

From individual delivery to scalable infrastructure

VeinTrain began, like most training organisations, delivering one course at a time. HALO exists because that model does not scale to a multi-site hospital group, a regional network or an international health system. HALO connects four things that used to sit apart: the physical product, now manufactured in the UK at volume; the digital learning route through the Online Skills Lab and Thinkific; the trainer and Train the Trainer support that keeps quality consistent as delivery spreads; and the implementation model that helps an organisation plan a rollout rather than book a one-off session.

This is also, deliberately, a story built on relationships and repeated delivery rather than a single announcement. The production capability behind this article did not appear overnight: it is the result of testing, iteration and a genuine partnership with a manufacturing and device partner VeinTrain has worked alongside over several months. That groundwork is what makes it possible to say, with confidence rather than hope, that VeinTrain is ready to support larger partnerships: hospital groups, regional systems and international programmes that need training infrastructure, not just training days.

What comes next

The professional video of the production run is still to come, and will sit alongside this article once it is ready. In the meantime, this is where VeinTrain is: a UK based specialist provider of IV Cannulation, venepuncture and phlebotomy training that can now manufacture its own products, at scale, with the learning, trainer and implementation infrastructure built around them from the start.